Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Adams WL, Yuan Z, Barboriak JJ, Rimm A (1993) Alcohol related hospita-lizations of elderly people: Prevalence and geographic variation in the United States. JAMA 270: 1222–1225
Agarwal DP, Goedde HW (1990) Alcohol metabolism, alcohol intolerance and alcoholism. Biochemical and pharmacological approaches. Springer, Berlin Heidelberg New York Tokyo
Agarwal-Kozlowski K, Agarwal DP (2000) Genetische Prädisposition zur Alkoholkrankheit. Therapeutische Umschau 57: 179–184
Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double blind, placebo-controlled trial. Gastroenterology 119: 1637–1648
Allemann PI (2000) Marker für übermäßigen Alkoholkonsum (Screening). Therapeutische Umschau 57: 185–190
Barwick KW, Rosai J (1996) Liver: Alcohol induced liver diseases. In: Acker-man’s surgical pathology, 8th ed, Vol I, Chap 13. Mosby Yearbook, St Louis, p 870–871
Bellentani S, Saccoccio G, Costa G (1997) Drinking habits as cofactors of risk for alcohol indurced liver damage. Gut 41: 845–850
Cabré E, Gonzales-Huiz F, Abad-LaCruz A (1990) Effect of total enteral nutrition on the short term outcome of severely malnourished cirrhotics. Gastroenterology 98: 715–720
Cabré E, Rodriguez-Iglesias P, Caballeria J et al. (2000) Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology 32: 36–42
DeFeo TM, Fargion S, Duca L et al. (1999) Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 29: 658–663
Deutsche Hauptstelle gegen die Suchtgefahren e.V. (DHS) Hamm (2000) Jahrbuch Sucht 2001, Neuland, Geesthacht
Grove J, Daly AK, Burt AD, Guzail M, James OF, Bassendine MF, Day CP (1998) Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 43: 262–266
Levin DL, Baker AL, Riddel RH (1979) Non alcoholic liver disease: Over-looked causes of liver injury in patients with heavy alcohol consumption. Am J Med 66: 429–443
Lieber CS (1998) Hepatic and other medical disorders of alcoholism: from pathogenesis to treatment. J Stud Alcohol 59: 9–25
Lieber CS (2000) Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol 32(Suppl. 1): 113–128
Maddrey WC, Boitnott JK, Bedine MS et al. (1978) Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 75: 193–199
Marik P, Mohedin B (1996) Alcohol-related admissions to an inner city hospital intensive care unit. Alcohol Alcohol 31: 393–396
Mathiesen UL, Franzén LE, Frydén A, Foberg U, Bodemar G (1994) The clinical significance of slightly to moderately increased liver trans-aminase values in asymptomatic patients. Scand J Gastroenterol 34: 85–91
Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, Valla D et al. (2003) Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 38: 1363–1369
Mathurin P, Duchatelle V, Ramond MJ (1996) Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 110: 1847–1853
McCullough AJ, O’Connor JFB (1998) Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 93: 2022–2036
Mezey E, Potter JJ, Rennie-Tankerley L, Caballeria J, Pares A (2004) A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 40: 40–46
Morgan MY (1996) The treatment of alcoholic hepatitis. Alcohol Alcohol 31: 117–134
Mundle G, Ackermann K, Munkes J, Steinle D, Mann K (1999) Influence of age, alcohol consumption and abstinence on the sensitivity of carbo-hydrate-deficient transferrin, γ-glutamyltransferase and mean corpus-cular volume. Alcohol Alcohol 34: 760–766
Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet MA, Davion T, et al. (2004) A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 39: 1390–1397
Neuberger J, Schulz K-H, Day C, Fleig WE et al. (2002) Transplantation for alcoholic liver disease. J-Hepatology 36:130–137
Pageaux GP, Michel J, Coste V et al. (1999) Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 45: 421–426
Productschäp for Gedistilleerde Dranken (1999) World drink trends 1999. NTC-Publications, Henley-on-Thames (UK)
Schenker S, Hoyumpa AM (1999) New concepts of dietary intervention in alcoholic liver disease. J Lab Clin Med 134: 433–434
Sogni P, Hadengue A, Moreau R et al. (1997) Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis. J Hepatol 26: 628–633
Sorbi D, Boynton J, Lindor KD (1999) The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalco-holic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 94: 1018–1022
Walsh K, Alexander G (2000) Alcoholic liver disease. Postgrad Med J 76: 280–286
Zylberberg H, Fontaine H, Thépot V, Nalpas B, Bréchot C, Pol S (1999) Triggering of acute alcoholic hepatitis by α-interferon therapy. J Hepatol 30: 722–725
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Heidelberg
About this chapter
Cite this chapter
Grothe, W., Fleig, W.E. (2005). Alkoholbedingte Lebererkrankungen. In: Schölmerich, J., et al. Medizinische Therapie 2005|2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27385-9_76
Download citation
DOI: https://doi.org/10.1007/3-540-27385-9_76
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-21226-3
Online ISBN: 978-3-540-27385-1
eBook Packages: Medicine (German Language)